Cargando…
Brain alpha‐amylase: a novel energy regulator important in Alzheimer disease?
Reduced glucose metabolism and formation of polyglucosan bodies (PGB) are, beside amyloid beta plaques and neurofibrillary tangles, well‐known pathological findings associated with Alzheimer's disease (AD). Since both glucose availability and PGB are regulated by enzymatic degradation of glycog...
Autores principales: | Byman, Elin, Schultz, Nina, Fex, Malin, Wennström, Malin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028266/ https://www.ncbi.nlm.nih.gov/pubmed/29485701 http://dx.doi.org/10.1111/bpa.12597 |
Ejemplares similares
-
Amylin alters human brain pericyte viability and NG2 expression
por: Schultz, Nina, et al.
Publicado: (2016) -
Alpha-amylase 1A copy number variants and the association with memory performance and Alzheimer’s dementia
por: Byman, Elin, et al.
Publicado: (2020) -
Neuronal α‐amylase is important for neuronal activity and glycogenolysis and reduces in presence of amyloid beta pathology
por: Byman, Elin, et al.
Publicado: (2021) -
Levels of Retinal Amyloid-β Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-β in Neuropathologically Evaluated Individuals
por: Schultz, Nina, et al.
Publicado: (2020) -
Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer’s disease
por: Schultz, Nina, et al.
Publicado: (2019)